Preserving Sponsored Research Integrity: Fortifying Contractual Language and University Policy to Prevent Bias and COI

Program agenda:

Contract issues:

• Intellectual property
  • Bayh Dole
  • Appropriate obligations on IP
  • Investigator-led projects
  • Sponsor-led projects
  • Appropriate commercialization terms
• Research integrity
  • Publication must be absolute
  • Appropriate delay for review
  • No editorial control by sponsor

Compliance issues:

• Ensuring appropriate data maintenance
• Ensuring appropriate regulatory control
  • IACUC
  • IRB
  • FDA
• Identifying conflicts of interest
• Appropriate COI management plans

Research collaborations between universities and industry have become commonplace and often offer critical benefits to both parties, advancing potentially valuable technologies that may have otherwise been delayed or discontinued.

But, these complex agreements come with great responsibility related to the integrity of research data, and the principal investigator’s ability to conduct, review and publish the research independently and without any hint of bias.

As more for-profit actors are added to the research stage, the spotlight also focuses more directly on the various conflicts of interest that can harm reputations and bring research partnerships to a screeching halt. That’s why we’ve secured two experts from UNeMed – the University Nebraska Medical Center’s tech transfer arm — to present this important, detailed program.

We’ll dive into best practices that universities can draw upon to ensure the integrity of their corporate-sponsored research through carefully drafted contractual language as well as optimal compliance and COI policies. Please join Joe Runge, Business Development Manager, and Tara Scrogin, Associate General Counsel for Health Sciences, for this comprehensive session.

Program Leaders